A single measles outbreak now carries a price tag that can run into the tens of millions of dollars, and new research from Johns Hopkins University is putting hard numbers on what public health officials have long suspected.
Quick Take
- Johns Hopkins researchers estimate the 2025 U.S. measles outbreak cost more than $37 million across 2,289 confirmed cases.
- The study reviewed outbreaks in 18 states from 2000 to 2025 to build its cost model.
- Researchers found a fixed response cost of about $244,000 per outbreak, plus roughly $16,000 for each additional case.
- Other versions of the same research put the total closer to $134 million, depending on which costs are counted.
What The Johns Hopkins Study Actually Found
Researchers at the Johns Hopkins Bloomberg School of Public Health’s International Vaccine Access Center built a tool to calculate what measles outbreaks cost the country. They reviewed outbreak data from 18 states spanning 25 years, then applied that model to the 2,289 confirmed measles cases reported in the United States in 2025. The result: an estimated economic hit of more than $37 million, according to CNBC’s reporting on the project.
That $37 million figure is not a guess pulled from thin air. The team broke outbreak spending into two buckets: a fixed cost of about $244,480 that public health departments pay to respond to an outbreak, and an incremental cost of roughly $16,197 for every case beyond the first. Those numbers cover contact tracing, quarantine enforcement, lab testing, and emergency vaccination campaigns, the unglamorous work that keeps a handful of cases from becoming a statewide crisis.
Why The Same Study Produces Different Headline Numbers
Depending on how you slice the data, the per-case cost estimate changes dramatically. The study’s range runs from about $33,416 per case using only a medical provider’s view to $58,591 per case once you fold in the full public health response. Multiply that higher number by the 2,289 confirmed 2025 cases, and you get a total closer to $134 million, not $37 million, which is exactly what some other outlets reported from the same underlying research.
That is not a contradiction. It is a reminder that “cost of measles” means different things to different accountants. A hospital counts emergency room visits and treatment. A health department counts staff hours spent knocking on doors and running vaccination clinics. An economist counts lost wages from parents who missed work to quarantine a sick kid. Depending on which lens you use, the price tag shifts by tens of millions of dollars, even though the underlying outbreak never changed.
Confirmed Cases Are Likely A Floor, Not A Ceiling
The 2,289 figure driving these estimates covers only confirmed cases. Measles can spread quietly before a rash and fever send someone to a doctor, and plenty of mild cases never get officially logged. That means the true 2025 toll, in both human and financial terms, is probably higher than any of these published figures suggest, since the model counts what health departments could verify, not necessarily every infection that occurred.
History Shows This Pattern Is Nothing New
This is not the first time measles economics have produced a wide spread of numbers. A review of 10 published studies covering 11 post-elimination U.S. outbreaks between 2001 and 2018 found a median cost of about $152,000 per outbreak and roughly $32,805 per case, but with totals ranging from under $10,000 to more than $1 million depending on outbreak size and how long investigators worked the case. A 2018-2019 Washington state outbreak of just 72 cases alone cost public health departments $3.2 million to contain.
What stays consistent across every study, old and new, is the underlying lesson: measles does not stay contained cheaply. Whether the final number lands near $37 million or closer to $134 million, every dollar reflects real contact tracers knocking on doors, real nurses running vaccination clinics, and real families losing income during quarantine. The debate over accounting methods matters for researchers. For taxpayers and parents, the message is simpler. Outbreaks that could have been prevented with routine childhood vaccination are now draining public health budgets that could be spent elsewhere, and the bill keeps climbing as cases rise.
“A new tool developed by researchers at Johns Hopkins University estimates that the 2025 measles outbreak in the U.S. — which involved roughly 2,300 confirmed cases nationwide — carried an economic cost of more than $37 million.” https://t.co/wtTC6YkvdH
— Amesh Adalja (@AmeshAA) November 11, 2026
Public health officials are using these figures to argue for sustained investment in vaccination infrastructure rather than reactive outbreak spending. Whether policymakers heed that argument is a separate fight. The math itself, drawn from two and a half decades of outbreak data across 18 states, is not in dispute.
Sources:
cnbc.com, pure.johnshopkins.edu, fastcompany.com, medrxiv.org, immunizationeconomics.org, publichealth.jhu.edu
